PubMed:32846167 / 636-822
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T4 | 52-57 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
| T5 | 127-145 | Body_part | denotes | glycosaminoglycans | http://purl.org/sig/ont/fma/fma63011 |
| T6 | 147-151 | Body_part | denotes | GAGs | http://purl.org/sig/ont/fma/fma63011 |
| T7 | 165-180 | Body_part | denotes | heparan sulfate | http://purl.org/sig/ont/fma/fma63023 |
| T8 | 182-184 | Body_part | denotes | HS | http://purl.org/sig/ont/fma/fma63023 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T12 | 32-44 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
| T13 | 73-88 | Disease | denotes | Type 2 diabetes | http://purl.obolibrary.org/obo/MONDO_0005148 |
| T14 | 80-88 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 52-57 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T10 | 127-145 | Chemical | denotes | glycosaminoglycans | http://purl.obolibrary.org/obo/CHEBI_18085 |
| T11 | 147-151 | Chemical | denotes | GAGs | http://purl.obolibrary.org/obo/CHEBI_18085 |
| T12 | 165-180 | Chemical | denotes | heparan sulfate | http://purl.obolibrary.org/obo/CHEBI_28815 |
| T13 | 165-172 | Chemical | denotes | heparan | http://purl.obolibrary.org/obo/CHEBI_24500 |
| T14 | 173-180 | Chemical | denotes | sulfate | http://purl.obolibrary.org/obo/CHEBI_16189 |
| T15 | 182-184 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T5 | 73-88 | Phenotype | denotes | Type 2 diabetes | http://purl.obolibrary.org/obo/HP_0005978 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 32-44 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
| T3 | 112-123 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | degradation |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 0-186 | Sentence | denotes | Several studies have shown that inflammation of the lungs in general and Type 2 diabetes are accompanied by the degradation of glycosaminoglycans (GAGs), especially heparan sulfate (HS). |
| T4 | 0-186 | Sentence | denotes | Several studies have shown that inflammation of the lungs in general and Type 2 diabetes are accompanied by the degradation of glycosaminoglycans (GAGs), especially heparan sulfate (HS). |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 0-186 | Sentence | denotes | Several studies have shown that inflammation of the lungs in general and Type 2 diabetes are accompanied by the degradation of glycosaminoglycans (GAGs), especially heparan sulfate (HS). |
LitCovid-PD-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
|---|---|---|---|---|---|
| T1 | 165-180 | GlycoEpitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
| T2 | 182-184 | GlycoEpitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 67 | 32-44 | Disease | denotes | inflammation | MESH:D007249 |
| 68 | 80-88 | Disease | denotes | diabetes | MESH:D003920 |
| 69 | 127-145 | Chemical | denotes | glycosaminoglycans | MESH:D006025 |
| 70 | 147-151 | Chemical | denotes | GAGs | MESH:D006025 |
| 71 | 165-180 | Chemical | denotes | heparan sulfate | MESH:D006497 |
| 72 | 182-184 | Chemical | denotes | HS | MESH:D006497 |